318 results on '"Barrett, A. John"'
Search Results
2. Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies
3. Occurrence and Mitigation of Bacterial Regrowth in Stored Household Water in Eastern Coastal Madagascar.
4. Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors
5. A review of American lobster (Homarus americanus) records around the British Isles: 2012 to 2018
6. Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation
7. Reprint of: Virus-Specific T Cells: Broadening Applicability
8. Virus-Specific T Cells: Broadening Applicability
9. Ex vivo T-cell–depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy
10. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report
11. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
12. Quantitative activation suppression assay to evaluate human bone marrow–derived mesenchymal stromal cell potency
13. Reductions in Children's Blood Lead Levels from a Drinking-Water Intervention in Madagascar, Sub-Saharan Africa.
14. The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century
15. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells
16. Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
17. The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches
18. Repair of Impaired Pulmonary Function Is Possible in Very-Long-Term Allogeneic Stem Cell Transplantation Survivors
19. Genetically engineered fixed K562 cells: potent “off-the-shelf” antigen-presenting cells for generating virus-specific T cells
20. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation
21. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
22. Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor‐mutated essential thrombocythemia
23. Convergence of Social Marketing and Engineering: A Lead Mitigation Study in Madagascar.
24. Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain
25. Problem- versus Case-based Approaches in Teaching Medical Students about Eating Disorders: A Controlled Comparison.
26. Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation
27. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy
28. Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome
29. Alloreactivity Across HLA Barriers Is Mediated by Both Naïve and Antigen-Experienced T Cells
30. Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
31. Tumor vaccines and beyond
32. Granulocyte Colony-Stimulating Factor Preferentially Stimulates Proliferation of Monosomy 7 Cells Bearing the Isoform IV Receptor
33. NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation
34. Rituximab Administration within 6 Months of T Cell-Depleted Allogeneic SCT is Associated with Prolonged Life-Threatening Cytopenias
35. Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
36. Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
37. NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction
38. Clinical Trial of Quantitative Real-Time Polymerase Chain Reaction for Detection of Cytomegalovirus in Peripheral Blood of Aflogeneic Hematopoietic Stem-Cell Transplant Recipients
39. Outbreak of Human Parainfluenza Virus 3 Infections in a Hematopoietic Stem Cell Transplant Population
40. The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
41. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation
42. High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow
43. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
44. Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib
45. Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies
46. Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
47. Persistence of Human Parvovirus B19 in Multipotent Mesenchymal Stromal Cells Expressing the Erythrocyte P Antigen: Implications for Transplantation
48. T Cell Therapy in Allogeneic Stem Cell Transplantation
49. Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation
50. Prophylaxis of acute GVHD: manipulate the graft or the environment?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.